ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 525

Evidence For Enhanced Induction Of Unfolded Protein Response Target Genes In Peripheral Blood Mononuclear Cells From Spondyloarthritis Patients

Grace Kwon1, Eva Yang1, Keith A. Sikora1, Hemalatha Srinivasalu2, Gerlinde Layh-Schmitt1 and Robert A. Colbert3, 1NIAMS NIH, Bethesda, MD, 2Rheumatology, NIAMS NIH, Bethesda, MD, 3NIAMS/NIH, Bethesda, MD

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: ER Stress and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis: Pathogenesis, Etiology, Animal Models I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Spondyloarthritis (SpA) is an immune-mediated inflammatory disease strongly associated with HLA-B27 (B27). In a transgenic rat model where B27 causes SpA-like disease, CD8 T cells that recognize B27 peptides are not required. B27 has a tendency to misfold, and when upregulated in rat cells can cause endoplasmic reticulum (ER) stress resulting in an unfolded protein response (UPR). The UPR can promote cytokine production and activate autophagy, and may be important in SpA pathogenesis. Since B27 transgenic rats carry multiple transgene copies, an important question is whether B27 upregulation in human cells is sufficient to cause ER stress. We sought to determine whether B27 upregulation in peripheral blood mononuclear cells (PBMC) activates the UPR.

Methods: PBMC from 25 healthy controls (HCs) and 32 adult or pediatric SpA patients (27 B27 positive) meeting age-appropriate classification criteria for SpA were cultured for 20 hours without or with IFNγ, TNFα, or both (IT). Total RNA was isolated and expression of HLA-B and UPR-target genes (BiP, XBP1) was quantitated by real-time PCR. Relative gene expression was determined by normalizing to 3 housekeeping genes, and fold change calculated by comparing treated and untreated samples with statistical assessment by Mann-Whitney U test. Correlations were assessed by Spearman’s. XBP1 mRNA splicing was determined on agarose gels.

Results: HLA-B expression increased 1.9-fold with IFNγ in SpA PBMC and 1.6-fold in HCs (p<0.05 SpA vs. HCs). When treated with TNFα or IT, HLA-B expression in SpA patients increased 1.3-fold and 2.1-fold, respectively, compared to 1.1-fold and 1.9-fold in healthy controls (NS SpA vs. HCs). BiP expression in TNFα-treated PBMC increased 1.3-fold in SpA patients vs. 1.1-fold in HCs (p=0.05) while no significant difference between SpA patients and HCs was seen with IFNγ (1.3-fold and 1.2 fold) or IT (1.3-fold and 1.3-fold). We also asked whether individual fold changes in BiP correlated with HLA-B upregulation. With IFNγ and/or TNFα treatment, fold change in BiP and XBP1 positively correlated with fold change in HLA-B in SpA patients (p<0.005), while in HCs significant correlation was only observed in TNFa-treated PBMC (p<0.05, p<0.005, respectively). More importantly, the slopes of the correlation plots between HLA-B and BiP or XBP1 were 1.3-2.3 times greater for SpA patients than HCs. In addition, XBP1 splicing was significantly increased by cytokine treatments in patient samples but not in HCs (p<0.05). Subanalyses of B27-positive and negative SpA patients is inconclusive due to the low number of B27-negative patients.

Conclusion: Our results reveal greater upregulation of the UPR-target gene BiP as well as increased XBP1 mRNA splicing in response to cytokines in SpA patients compared to HCs. These preliminary results support the idea that low-level HLA-B27 upregulation may be sufficient to generate ER stress in certain cell types. Further exploration of cell types affected by this response, and additional conditions that may enhance B27 heavy chain accumulation, is necessary to better understand the potential role of ER stress in SpA pathogenesis.

 


Disclosure:

G. Kwon,
None;

E. Yang,
None;

K. A. Sikora,
None;

H. Srinivasalu,
None;

G. Layh-Schmitt,
None;

R. A. Colbert,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evidence-for-enhanced-induction-of-unfolded-protein-response-target-genes-in-peripheral-blood-mononuclear-cells-from-spondyloarthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology